Liver diseases have been renamed for the first time in about 56 years. The new names come after decades of criticism, with the hope that the changes will lead to more understanding and research interest in liver diseases. Non-alcoholic fatty liver disease was renamed to metabolic dysfunction-associated steatotic liver disease. The new names and definitions are considered more accurate, and they should help to clarify what the disease is rather than what it isn’t. The new nomenclature will also be used to educate patients and healthcare providers about liver diseases. This change is also seen as a step towards breaking the fruitless cycle of failed liver disease trials.
Source link
Why liver experts renamed NASH to MASH, and NAFLD to MASLD
